PharmiWeb.com - Global Pharma News & Resources

Research and development - Press Releases

Date Title Company
07-Apr-2023 Alfa Chemistry Supports Various Research Fields Using Stable Isotope Related Technical Services Alfa Chemistry
06-Apr-2023 UK biotech start-up secures £1.27M to revolutionise intracellular drug delivery through tumour targeted technology Vitarka Therapeutics
05-Apr-2023 Discovery Park’s New Lab Complex is Attracting Tenants Ahead Of Opening Discovery Park
04-Apr-2023 Spin-out raises £3m to develop world's first testosterone patch for post-menopausal women Medherant
04-Apr-2023 HUTCHMED Initiates Registration Phase Enrollments of HMPL-453 for IHCC and Savolitinib for Gastric Cancer following NMPA Consultations HUTCHMED
04-Apr-2023 Over DKK 3 billion (USD 413 million) raised by BioInnovation Institute portfolio companies to date BioInnovation Institute (BII)
04-Apr-2023 AMSilk Announces Extension of Series C Financing to EUR 54M AMSilk
04-Apr-2023 IRBM Selected for Participation in National Chemical Biology Consortium IRBM
04-Apr-2023 ISCT 2023 Paris harnessing global expertise and enabling collaboration to drive advanced therapies to patients The International Society for Cell & Gene Therapy
04-Apr-2023 midge medical partners with the Institut Pasteur de Dakar to offer an easy and affordable innovative detection solution for Marburg Virus midge medical
04-Apr-2023 Sequana Medical announces submission of Investigational New Drug (IND) application for DSR® 2.0 for treatment of congestive heart failure Sequana Medical
03-Apr-2023 Major Players Invest Significantly in Lab Automation Market to Diversify Product Offerings and Secure Market Positions Regal Intelligence
03-Apr-2023 EBViously Announces First Details of Its EBV-001 Vaccine Candidate for the Prevention of Epstein-Barr Virus (EBV)-Induced Diseases EBViously
31-Mar-2023 TOPTICA is growing TOPTICA
31-Mar-2023 LEADING MICROBIOLOGY TESTING FACILITY INVESTS IN THE FUTURE Wickham Micro
31-Mar-2023 HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer HUTCHMED
30-Mar-2023 MedPharm Announces Appointment of New U.S. Director of Analytical MedPharm
30-Mar-2023 A Series of Colloidal Materials Newly Launched at Alfa Chemistry: Catalysts, Nanoparticles, and Silica Alfa Chemistry
29-Mar-2023 Bimuno® GOS approved by Health Canada for use in Natural Health Products and obtains 10 health claims Clasado Biosciences
29-Mar-2023  Alfa Chemistry Exhibits Expertise in Flame Retardant Performance Analysis and Innovative Flame Retardant Design Alfa Chemistry